Goldman Sachs’s Zai Lab ZLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.08M | Sell |
110,587
-38,847
| -26% | -$720K | ﹤0.01% | 4508 |
|
|
2025
Q4 | $2.64M | Buy |
149,434
+67,253
| +82% | +$1.57M | ﹤0.01% | 4335 |
|
|
2025
Q3 | $2.79M | Sell |
82,181
-62,141
| -43% | -$2.14M | ﹤0.01% | 4185 |
|
|
2025
Q2 | $5.05M | Buy |
144,322
+70,731
| +96% | +$2.33M | ﹤0.01% | 3410 |
|
|
2025
Q1 | $2.66M | Sell |
73,591
-157,337
| -68% | -$4.84M | ﹤0.01% | 3915 |
|
|
2024
Q4 | $6.05M | Sell |
230,928
-20,579
| -8% | -$571K | ﹤0.01% | 3261 |
|
|
2024
Q3 | $6.07M | Sell |
251,507
-44,452
| -15% | -$840K | ﹤0.01% | 3172 |
|
|
2024
Q2 | $5.13M | Sell |
295,959
-2,622
| -0.9% | -$46.1K | ﹤0.01% | 3127 |
|
|
2024
Q1 | $4.78M | Buy |
298,581
+149,276
| +100% | +$3.14M | ﹤0.01% | 3132 |
|
|
2023
Q4 | $4.08M | Buy |
149,305
+112,046
| +301% | +$2.96M | ﹤0.01% | 3335 |
|
|
2023
Q3 | $906K | Sell |
37,259
-48,152
| -56% | -$1.28M | ﹤0.01% | 4335 |
|
|
2023
Q2 | $2.37M | Sell |
85,411
-105,623
| -55% | -$3.45M | ﹤0.01% | 3739 |
|
|
2023
Q1 | $6.35M | Sell |
191,034
-390,336
| -67% | -$15M | ﹤0.01% | 2827 |
|
|
2022
Q4 | $17.8M | Buy |
581,370
+421,639
| +264% | +$13.3M | ﹤0.01% | 2067 |
|
|
2022
Q3 | $5.46M | Sell |
159,731
-888
| -0.6% | -$38K | ﹤0.01% | 3056 |
|
|
2022
Q2 | $5.57M | Sell |
160,619
-155,984
| -49% | -$5.5M | ﹤0.01% | 3038 |
|
|
2022
Q1 | $13.9M | Sell |
316,603
-114,640
| -27% | -$5.54M | ﹤0.01% | 2361 |
|
|
2021
Q4 | $27.1M | Buy |
431,243
+166,739
| +63% | +$14.1M | 0.01% | 1853 |
|
|
2021
Q3 | $27.9M | Sell |
264,504
-8,977
| -3% | -$1.29M | 0.01% | 1754 |
|
|
2021
Q2 | $48.4M | Sell |
273,481
-57,905
| -17% | -$9.32M | 0.01% | 1289 |
|
|
2021
Q1 | $44.2M | Sell |
331,386
-134,655
| -29% | -$20.8M | 0.01% | 1269 |
|
|
2020
Q4 | $63.1M | Sell |
466,041
-590,183
| -56% | -$60.1M | 0.02% | 939 |
|
|
2020
Q3 | $87.8M | Buy |
1,056,224
+157,512
| +18% | +$12.6M | 0.02% | 643 |
|
|
2020
Q2 | $73.8M | Buy |
898,712
+708,765
| +373% | +$47.9M | 0.02% | 698 |
|
|
2020
Q1 | $9.78M | Buy |
189,947
+71,855
| +61% | +$3.75M | ﹤0.01% | 2103 |
|
|
2019
Q4 | $4.91M | Buy |
118,092
+94,670
| +404% | +$3.49M | ﹤0.01% | 2974 |
|
|
2019
Q3 | $758K | Buy |
23,422
+13,717
| +141% | +$471K | ﹤0.01% | 4204 |
|
|
2019
Q2 | $338K | Sell |
9,705
-17,120
| -64% | -$504K | ﹤0.01% | 4571 |
|
|
2019
Q1 | $792K | Buy |
26,825
+15,714
| +141% | +$430K | ﹤0.01% | 4184 |
|
|
2018
Q4 | $258K | Buy |
+11,111
| New | +$206K | ﹤0.01% | 4705 |
|
|
2018
Q2 | – | Sell |
-20,720
| Closed | -$442K | – | 6078 |
|
|
2018
Q1 | $442K | Buy |
+20,720
| New | +$470K | ﹤0.01% | 4558 |
|
|
2017
Q4 | – | Sell |
-41,700
| Closed | -$1.13M | – | 6699 |
|
|
2017
Q3 | $1.13M | Buy |
+41,700
| New | +$1.16M | ﹤0.01% | 4475 |
|
Other funds holding ZLAB
RI
RCM
FLSM
ACM
RSCM
CWG
Goldman Sachs's ZLAB Position: Q1 2026 in Review
Goldman Sachs reduced its Zai Lab (ZLAB) stake by 26% in Q1 2026, selling an estimated $720K and leaving 110,587 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4508.
Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 32 quarters since. The position peaked at $87.8M in Q3 2020. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.
- Goldman Sachs held 110,587 shares of Zai Lab worth $2.08M as of Q1 2026.
- Goldman Sachs sold 38,847 Zai Lab shares in Q1 2026, an estimated $720K.
- Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4508 holding.
- Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 32 quarters since.
- Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
- 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.